LouisVPunekyMD

Oncology • Jackson, MS

Associate Professor, Medicine, University of Mississippi School of Medicine

Join to view full profile

Dr. Puneky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Puneky's full profile

Already have an account?

Office
2500 North State Street
Department Of Medicine/Division Of Oncology
Jackson, MS 39216
Phone+1 601-984-5590
Is this information wrong?

Education & Training

University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991
University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
University of Mississippi Medical CenterResidency, Internal Medicine, 1985 - 1988
Louisiana State University School of Medicine in New OrleansClass of 1985

Certifications & Licensure

MS State Medical License 1986 - 2024
LA State Medical License 1985 - 2000
AL State Medical License Active through 1994
American Board of Internal Medicine Internal Medicine

Clinical Trials

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
Active, not recruiting
Phase 3
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer Start of enrollment: 2009 Feb 01
Completed
Phase 2
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
Completed
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

13 citations
Favorable Response of Metastatic Hepatocellular Carcinoma to Treatment with Trans-arterial Radioembolization Followed by Sorafenib and Nivolumab.
Charles S Adcock, Louis V. Puneky, Garth Campbell> ;Cureus. 2019 Feb 16
Invasive Pancreatic Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of Heterotopic Pancreatic Origin Located in the Stomach.
Christopher, W. O., Earl, T. M., Puneky, L. V., Seawright, A. H., Wynn, J. J., Anderson, C. D., Orr, W. S.> ;The American surgeon. 2017 Sep 30
2 citations
Invasive Pancreatic Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of Heterotopic Pancreatic Origin Located in the Stomach.
Wade O. Christopher, Truman M. Earl, Louis V. Puneky, A.H. Seawright, James J. Wynn, Christopher D. Anderson, W. Shannon Orr> ;The American Surgeon. 2017 Sep 1
Invasive Pancreatic Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of Heterotopic Pancreatic Origin Located in the Stomach.
Christopher, W. O., Earl, T. M., Puneky, L. V., Seawright, A. H., Wynn, J. J., Anderson, C. D., Orr, W. S.> ;The American surgeon. 2017 Sep 1
39 citations
Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis
Ahmed A. Ejaeidi, Barbara S. Craft, Louis V. Puneky, Robert E. Lewis, Julius M. Cruse> ;Experimental and Molecular Pathology. 2015 Aug 1
39 citations
Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells
Mark F. Santos, Venkat K.R. Mannam, Barbara S. Craft, Louis V. Puneky, Natale T. Sheehan, Robert E. Lewis, Julius M. Cruse> ;Experimental and Molecular Pathology. 2014 Jun 1
26 citations
A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecolog...
David Miller, John A. Blessing, Richard D. Drake, Robert V. Higgins, D. Scott McMeekin, Louis V. Puneky, Carolyn N. Krasner> ;Gynecologic Oncology. 2009 Dec 1
20 citations
A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study.
James Fiorica, John A. Blessing, Louis V. Puneky, Angeles Alvarez Secord, James S. Hoffman, S. Diane Yamada, Thomas E. Buekers, Jeffrey G. Bell, Jeanne M. Schilder> ;Gynecologic Oncology. 2009 Nov 1
A phase II evaluation of pemetrexed (ALIMTA, LY231514, IND#40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologi...
Miller DS, Blessing JA, Krasner CN, Drake RD, Higgins R, McMeekin DS, Puneky LV> ;J. Clin. Oncol.. 2009-05-20
31 citations
Chemotherapy as a palliative treatment in carcinoma of the uterine cervix.
James Tate Thigpen, Ralph B. Vance, Louis V. Puneky, Tawfiq Khansur> ;Seminars in Oncology. 1995 Apr 1
47 citations
Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Tate Thigpen, Ralph B. Vance, Louis V. Puneky, Tawfiq Khansur> ;Gynecologic Oncology. 1994 Dec 1
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Mississippi Baptist Medical CenterJackson, Mississippi
St. Dominic-Jackson Memorial HospitalJackson, Mississippi
University of Mississippi Medical CenterJackson, Mississippi